BlackRock’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$31.8M Sell
3,315,348
-8,255
-0.2% -$79.2K ﹤0.01% 2718
2025
Q1
$20.8M Sell
3,323,603
-178,772
-5% -$1.12M ﹤0.01% 2884
2024
Q4
$28.4M Buy
3,502,375
+379,805
+12% +$3.08M ﹤0.01% 2780
2024
Q3
$56.5M Buy
3,122,570
+196,197
+7% +$3.55M ﹤0.01% 2371
2024
Q2
$30.1M Buy
2,926,373
+180,993
+7% +$1.86M ﹤0.01% 2692
2024
Q1
$29.2M Buy
2,745,380
+66,489
+2% +$706K ﹤0.01% 2721
2023
Q4
$24.5M Buy
2,678,891
+241,149
+10% +$2.2M ﹤0.01% 2845
2023
Q3
$25.3M Buy
2,437,742
+435,110
+22% +$4.51M ﹤0.01% 2758
2023
Q2
$28.7M Buy
2,002,632
+369,722
+23% +$5.29M ﹤0.01% 2750
2023
Q1
$11.7M Sell
1,632,910
-61,521
-4% -$439K ﹤0.01% 3168
2022
Q4
$19M Buy
1,694,431
+151,281
+10% +$1.7M ﹤0.01% 3005
2022
Q3
$17.1M Sell
1,543,150
-34,587
-2% -$383K ﹤0.01% 3070
2022
Q2
$13.3M Buy
1,577,737
+199,220
+14% +$1.68M ﹤0.01% 3274
2022
Q1
$18.8M Sell
1,378,517
-94,608
-6% -$1.29M ﹤0.01% 3138
2021
Q4
$29M Buy
1,473,125
+290,247
+25% +$5.71M ﹤0.01% 2980
2021
Q3
$38M Buy
1,182,878
+22,441
+2% +$720K ﹤0.01% 2812
2021
Q2
$39.3M Buy
1,160,437
+344,497
+42% +$11.7M ﹤0.01% 2812
2021
Q1
$30.6M Buy
815,940
+25,060
+3% +$941K ﹤0.01% 2892
2020
Q4
$26.3M Buy
790,880
+73,968
+10% +$2.46M ﹤0.01% 2810
2020
Q3
$26.3M Sell
716,912
-9,015
-1% -$331K ﹤0.01% 2641
2020
Q2
$23.9M Buy
725,927
+140,981
+24% +$4.64M ﹤0.01% 2664
2020
Q1
$15.1M Sell
584,946
-55,769
-9% -$1.44M ﹤0.01% 2718
2019
Q4
$20M Buy
+640,715
New +$20M ﹤0.01% 2851